The ERN RARE-LIVER EASL ACADEMY 2025 will be hosted by the university hospital of Heidelberg and will focus on rare liver diseases with special focus on translating clinical practice guidelines in real-life care. The university hospital of Heidelberg is dedicated to advancing the understanding and treatment of rare liver diseases and the complex challenges in real-life care for patients with rare liver diseases.

The primary objectives of the ERN RARE-LIVER EASL ACADEMY 2025 are to:

• Enhance the understanding and practical management of rare liver diseases in light of the ERN-EASL-guidelines and discuss the guidelines content and translation to the clinic interactively between speakers and ERN RARE LIVER participants.
• Facilitate knowledge exchange between experts and young fellows in the field.
• Promote multidisciplinary collaboration in the treatment of rare liver diseases.
• Encourage the development of innovative approaches to patient care and treatment strategies.

The program will be a blend of expert talks, interactive case discussions and collaborative activities between experts and young fellows. Our setup will deal with the optimal translation of EASL-ERN clinical guideline knowledge into real-life practice with special focus on difficulties in diagnosis, treatment as well as opportunities and challenges in long-term management of rare liver diseases.

We are honored to propose a distinguished faculty for the ACADEMY, consisting of renowned experts in the field of hepatology and rare liver diseases:

Medical University of Heidelberg, Germany

Dr. Michael Dill, Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Heidelberg, Germany

Dr. Alexander Fichtner, Center for Child and Adolescent Medicine, Pediatric Gastroenterology, Hepatology and Nutrition, University Hospital Heidelberg, Germany

Priv.-Doz. Dr. Dominic Lenz, Center for Child and Adolescent Medicine, Division of Pediatric Neurology and Metabolic Medicine and Pediatric Gastroenterology, Hepatology and Nutrition, University Hospital Heidelberg, Germany

Prof. Dr. Thomas Longerich, Institute of Pathology, University Hospital Heidelberg, Germany

Prof. Dr. Uta Merle, Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Heidelberg, Germany

Dr. Isabelle Mohr, Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Heidelberg, Germany

Prof. Dr. Christian Schaaf, Institute of Human Genetics, Heidelberg University Hospital, Germany

Prof. Dr. Peter Schirmacher, Institute of Pathology, University Hospital Heidelberg, Germany

Prof. Dr. Karl Heinz Weiss, Salem Hospital Heidelberg, Germany

Medical University Amsterdam, Netherland

Prof. Dr. Joost Drenth, Department of Gastroenterology Endocrinology Metabolism, University Hospital Amsterdam, Netherlands

Medical University Vienna, Austria

Prof. Dr. Michael Trauner, Department of Gastroenterology and Hepatology, University Hospital Vienna, Austria

Medical University Hamburg, Germany

Prof. Dr. Christoph Schramm, Martin-Zeitz-Center for Rare Diseases Hamburg and Department of Gastroenterology and Hepatology, University Hospital Hamburg, Germany

Medical University of Warsaw, Poland

Prof. Dr. Piotr Socha, Department of Gastroenterology, Hepatology, Nutritional Disorders and Pediatrics, Children’s Memorial Health Institute, Warsaw, Poland